JTBR
BMRN icon

James T. Borello RIA’s BioMarin Pharmaceuticals BMRN Stock Holding History

James T. Borello RIA’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.2K Buy
220
+11
+5% +$693 ﹤0.01% 531
2026
Q2 		$12K Buy
209
+62
+42% +$3.4K ﹤0.01% 549
2026
Q1 		$8.3K Buy
147
+45
+44% +$2.62K ﹤0.01% 617
2025
Q4 		$6.06K Sell
102
-106
-51% -$5.77K ﹤0.01% 527
2025
Q3 		$11.3K Buy
+208
New +$11.9K ﹤0.01% 294

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Secure Asset Management
Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
First Financial Bank - Trust Division
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
PCMU
Paragon Capital Management (Utah) Provo, Utah $132M AUM 24.83% 1-Year Est. Return

James T. Borello RIA's BMRN Position: Q3 2026 in Review

James T. Borello RIA increased its BioMarin Pharmaceuticals (BMRN) stake by 5.3% in Q3 2026, buying an estimated $693 and bringing the position to 220 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #531.

James T. Borello RIA first reported a position in BMRN in Q3 2025 and has held it in 5 quarters since. 66 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • James T. Borello RIA held 220 shares of BioMarin Pharmaceuticals worth $13.2K as of Q3 2026.
  • James T. Borello RIA bought 11 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $693.
  • BioMarin Pharmaceuticals made up ﹤0.01% of James T. Borello RIA's portfolio in Q3 2026, its #531 holding.
  • James T. Borello RIA first reported a position in BioMarin Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 66 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.